BRUTRYHEAL FORTE

Introduction

BRUTRYHEAL FORTE is a prescription medicine containing Bromelain 180 mg, Trypsin 96 mg, and Rutoside 200 mg, a well-established oral enzyme and bioflavonoid combination used for the management of pain, inflammation, and soft tissue swelling associated with various inflammatory conditions.

The combination has been clinically evaluated for reducing inflammatory edema and improving recovery following surgical procedures, traumatic soft tissue injuries, and osteoarthritis. Bromelain and Trypsin are proteolytic enzymes that help modulate the inflammatory response and facilitate the resolution of inflammatory edema, while Rutoside is a flavonoid with antioxidant and capillary-protective properties that helps reduce vascular permeability and tissue swelling.

When prescribed by a healthcare professional, BRUTRYHEAL FORTE helps relieve pain, reduce inflammation and swelling, and support functional recovery in patients with inflammatory musculoskeletal and post-operative conditions.

Uses of BRUTRYHEAL FORTE

BRUTRYHEAL FORTE is indicated for the symptomatic management of pain, inflammation, and soft tissue swelling.

It may be prescribed for:

1. Osteoarthritis
2. Soft tissue injuries
3. Traumatic inflammatory conditions
4. Post-operative pain and inflammatory swelling
5. Recovery following orthopedic and general surgical procedures, as advised by a healthcare professional

Note: BRUTRYHEAL FORTE provides symptomatic relief and should be used as part of an overall treatment plan determined by the treating physician.

Benefits of BRUTRYHEAL FORTE

BRUTRYHEAL FORTE combines two proteolytic enzymes and a bioflavonoid that work through complementary mechanisms to help manage inflammatory conditions.

Scientific benefits include:

1. Helps reduce pain, inflammation, and soft tissue swelling.
2. Supports resolution of inflammatory edema following trauma and surgical procedures.
3. Helps improve joint pain and physical function in patients with osteoarthritis.
4. Supports recovery by reducing inflammatory swelling associated with soft tissue injuries.
5. Bromelain exhibits anti-inflammatory and anti-edematous properties through modulation of inflammatory mediators.
6. Trypsin assists in the breakdown of inflammatory protein by-products, supporting the natural resolution of inflammation.
7. Rutoside provides antioxidant activity and helps maintain capillary integrity, contributing to reduced vascular permeability and tissue edema.
8. Fixed-dose combination offers convenient administration and may improve treatment adherence.

How BRUTRYHEAL FORTE Works

BRUTRYHEAL FORTE works through the complementary pharmacological actions of its three active ingredients.

Bromelain is a proteolytic enzyme derived from pineapple that helps modulate inflammatory mediators, reduce tissue edema, and support the body's natural inflammatory resolution process.

Trypsin is a proteolytic enzyme that facilitates the breakdown of inflammatory protein by-products, helping reduce soft tissue swelling and promote recovery from inflammatory conditions.

Rutoside (Rutin) is a naturally occurring flavonoid with antioxidant and capillary-protective properties. It helps stabilize capillary permeability, reduce oxidative stress, and minimize fluid leakage into inflamed tissues, thereby contributing to reduced swelling.

Together, these complementary mechanisms help relieve pain, reduce inflammation and edema, and support recovery of affected tissues.

Dosage & Administration

BRUTRYHEAL FORTE should be used only under the supervision of a qualified healthcare professional.

General Adult Dosage

1. Take the medicine exactly as prescribed by the treating physician.
2. For optimal therapeutic effect, BRUTRYHEAL FORTE is generally recommended to be taken on an empty stomach, at least 30 minutes to 1 hour before meals or 2 hours after meals, unless otherwise directed by your healthcare professional.
3. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
4. Continue treatment for the full duration prescribed, even if symptoms improve earlier.
5. Do not discontinue treatment without consulting your healthcare provider.

Possible Side Effects

Like all medicines, BRUTRYHEAL FORTE may cause side effects, although many patients tolerate treatment well.

Commonly reported side effects include:

1. Nausea
2. Indigestion
3. Abdominal discomfort
4. Diarrhea
5. Vomiting
6. Skin rash
7. Mild allergic reactions

Patients should discontinue the medicine and seek immediate medical attention if they develop severe allergic reactions, persistent gastrointestinal symptoms, or unusual bleeding.

Contraindications & Precautions

BRUTRYHEAL FORTE should not be used in patients with:

1. Known hypersensitivity to Bromelain, Trypsin, Rutoside, pineapple-derived products, or any component of the formulation.
2. Active bleeding disorders.
3. Severe coagulation abnormalities.
4. Known allergy to proteolytic enzymes.

Important Precautions

BRUTRYHEAL FORTE should be used with caution in patients with:

1. Patients receiving anticoagulant or antiplatelet therapy, as Bromelain may increase the risk of bleeding.
2. Recent major surgery, unless prescribed by the treating physician.
3. Severe hepatic or renal impairment.
4. Pregnancy or breastfeeding, only if considered appropriate by the treating physician.

Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, herbal products, and dietary supplements before starting BRUTRYHEAL FORTE, as potential drug interactions may occur.

Disclaimer

The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. BRUTRYHEAL FORTE is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Patients should always follow their physician's advice regarding dosage, duration of treatment, and monitoring. Clinical decisions should be individualized based on the patient's medical condition, medical history, and current evidence-based clinical practice.